Event details

Speaker: Marianne Fillion Head of Precision Medicine and Diagnostics

Convenor: Hilary Worton, VP Client Engagement, APLUSA

Aims of Webinar

Leveraging PMR for Diagnostic Strategy For diagnostics and precision medicine assets. PMR can be valuable to you and your team throughout the product lifecycle, but here are some key “moments” What does it provide to your Dx and CDx team? Answers, Warnings, Guidance, Solutions, Strategies. Case study: Business Impact Utilisation of a rare disease panel amongst GPs in Europe. Maximizing PMR Value Challenges and hurdles to diagnostic market research, and how to minimise them. Strategies for maximising ROI of your research project. How do you know your research is valuable? DNA acrostic. Live Q&A

Key Takeaways:

Market research is often underutilised in diagnostic development and in precision medicine. It is a valuable tool to provide insight and directions into product development, to forecast drivers and barriers and identify solutions to mitigate hurdles throughout the product lifecycle. It is essential to ensuring access to testing to all patients who are candidate for targeted therapies, as it provides critical information on patient leakage due to testing.

Speaker: Marianne Fillion Head of Precision Medicine and Diagnostics

Marianne joined Purdie Pascoe in 2021, with more than 20 years’ experience in specialty pharmaceutical market research and strategy. Prior to joining PP, Marianne held the Head of Market Research and subsequently Head of Commercial Analytics and strategy positions at Diaceutics.  Marianne’s experience spans several complex therapeutic indications and includes all types of global market research studies. She has a specific and unique expertise in precision medicine, diagnostics and oncology market research, complemented by an MSc in Molecular Biology.